In detail, the following markers were found to be independent predictors of eGFR loss: serum kidney injury molecule-1 (KIM-1), in patients with T1D [110], and urinary levels of KIM-1 [111–113], β2-microglobulin [113], liver-type fatty acid-binding protein (FABP) [114], and nonalbumin protein [115], and serum retinol-binding protein 4 (RBP4) [107], in patients with T2D. Here, RBP4 is linked to type 1 diabetes mellitus.